0
0
Industry
Geography
Report Type
Themes
Price
Publication date
Published Date
  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Xenetic Biosciences Inc

    Xenetic Biosciences Inc (Xenetic Biosciences), formerly General Sales & Leasing Inc, is a biopharmaceutical company. It discovers and develops biologic drugs and novel orphan oncology therapeutics. Its pipeline products include Virexxa, ErepoXen, and OncoHist. Xenetic Biosciences' lead product candidate ErepoXen is a polysialylated form of erythropoietin used to treat anemia in pre-dialysis patients with chronic kidney disease. The company’s Virexxa and OncoHist are used for the treatment of progesterone receptor negative endometrial cancer and refractory acute myeloid leukemia. It also...

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Cogent Biosciences Inc

    Cogent Biosciences Inc (Cogent Biosciences) formerly, Unum Therapeutics Inc is a clinical-stage biopharmaceutical company that develops and commercializes precision therapies for genetically defined diseases. The company's pipeline product portfolio includes CGT9486 which is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis, a serious disease caused by the unchecked proliferation of mast cells....

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Kaleido Biosciences Inc

    Kaleido Biosciences Inc (Kaleido) is a pharmaceutical company. It carries out the design and development of human microbiomes for the treatment of infectious, inflammatory, oncology, and metabolic diseases. Its proprietary product platform enables the discovery and development of novel microbiome metabolic therapies which are designed to modulate the metabolic output by function and distribution of the gut’s existing microbes. The company is investigating KB195, for treatment of urea cycle disorders; KB174, targeting hepatic encephalopathy; KB295, for treating inflammatory bowel disease;...

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Neurocrine Biosciences Inc

    Neurocrine Biosciences Inc (Neurocrine) discovers, develops, and sells pharmaceutical products for the treatment of neurologic, neuropsychiatric, and neuroendocrine-related diseases and disorders. Its lead product, Ingrezza (valbenazine) capsule, is a US FDA-approved selective vesicular monoamine transporter 2 inhibitor for the treatment of adults with tardive dyskinesia (TD). The company's major pipeline products include valbenazine in Phase III clinical trials for the treatment of chorea in Huntington’s disease and adjunctive treatment of Schizophrenia; NBI-1065846 in Phase II clinical trial for anhedonia in...

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Pulse Biosciences Inc

    Pulse Biosciences Inc (Pulse Biosciences) is a clinical-stage electroceutical company. It offers pursuing applications of its novel and proprietary Nano-Pulse Stimulation technology. The company carries out development of novel and proprietary platform technology called Nano-Pulse Electro-Signaling (NPES) for clinical applications. Its NPES is a local and drug-free treatment that utilizes nanosecond pulsed electric fields to induce cell signaling and activate cellular pathways in tissue. Pulse Biosciences’ NPES technology is used in applications such as dermatology, oncology, minimally invasive treatments, aesthetics...

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Arcus Biosciences Inc

    Arcus Biosciences Inc (Arcus Biosciences) operates as a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies by leveraging underexploited biological opportunities. Its product pipeline includes AB928, a selective dual antagonist of the adenosine receptors known as A2aR and A2bR in combination with anti-PD-1 antibody (AB122) and chemotherapy is used for the treatment of metastatic triple-negative breast cancer or ovarian cancer and advanced malignancies; AB122, an anti-PD-1 antibody targeting cancer; AB154, an anti-TIGIT antibody; and AB680, a CD73 inhibitor against...

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Evelo Biosciences Inc

    Evelo Biosciences Inc (Evelo Biosciences) is a biotechnology company. It develops orally delivered product candidates for the treatment of inflammatory diseases and cancer. The company is investigating pipeline product EDP1815 and EDP1867, targeting SARS-CoV-2 virus, psoriasis, atopic dermatitis, and inflammatory diseases; and EDP1908, an anti-PD-1 therapy for multiple cancers. Its proprietary Sintax, an integrated platform develops oral biologics which harness the cells in the small intestine. Evelo Biosciences is also evaluating novel therapies to treat chronic diseases and cancer. The...

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Meridian Bioscience Inc

    Meridian Bioscience Inc (Meridian) is a fully integrated life science company that develops, manufactures and distributes diagnostic test kits for viral, gastrointestinal, respiratory and parasitic infectious disease indications. The company also manufactures bulk antigens, antibodies, purified reagents, nucleotides and related products for use in research and diagnostic manufacturing. It develops proteins and other biological materials for use in biotechnology research for new drugs and vaccines. Meridian offers its products to acute care hospitals, outpatient clinics, reference laboratories and physician office...

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Dare Bioscience Inc

    Dare Bioscience Inc (Dare Bioscience), formerly Cerulean Pharma Inc, is a biopharmaceutical company that develops products for women’s reproductive health. The company, through its dynamic tumor targeting platform, creates nanoparticle drug conjugates to attack tumor cells, reduce toxicity by sparing the body's normal cells, and enable therapeutic combinations. It offers products that include ovaprene, a clinical stage, non-hormonal contraceptive ring that provides protection over multiple weeks of use; and topical 5% sildenafil citrate cream for women with female sexual arousal...

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Akers Biosciences Inc

    MyMD Pharmaceuticals, Inc (MyMD), formerly, Akers Biosciences Inc is a medical device company that develops, manufactures and supplies point-of-care screening and testing products. The company provides clinical diagnostics, safety diagnostics, and wellness products. ABI products include BreathScan alcohol detectors, CHUBE, METRON, PIFA PLUSS PF4, tri-cholesterol, PIFA chlamydia, PIFA dengue fever, PIFA malaria, PIFA syphilis, PIFA heparin, and breath ketone. The company provides testing platform technologies, which include micro particle catalyzed biosensor, particle immune-filtration assay, rapid enzymatic assay, rapid blood cell...

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.